Jump to content

Page values for "Citalopram"

"Medicines" values

1 row is stored for this page
FieldField typeValue
genericStringCitalopram
brandStringCelexa
structureFile
classesList of String, delimiter: ,[[:Category:SSRIs|Selective serotonin reuptake inhibitor (SSRI)]] [[:Category:Antidepressants|Antidepressant]]
mechanismString'"`UNIQ--vote-0000001D-QINU`"' CYP2C19 + CYP3A4 metabolism, with CPIC PGx guidance: poor CYP2C19 metabolizers have ~3-fold higher exposure and benefit from a lower starting dose; ultrarapid metabolizers may have inadequate response'"`UNIQ--ref-0000001E-QINU`"'.
usesString'"`UNIQ--vote-0000001F-QINU`"', '"`UNIQ--vote-00000020-QINU`"', '"`UNIQ--vote-00000021-QINU`"', '"`UNIQ--vote-00000022-QINU`"', '"`UNIQ--vote-00000023-QINU`"', '"`UNIQ--vote-00000024-QINU`"', '"`UNIQ--vote-00000025-QINU`"'
starting_doseString20 mg PO once daily; titrate to 40 mg/day after 1 week if tolerated. Elderly (>60) and hepatic impairment: 20 mg/day ceiling
preparationsStringTablets 10, 20, 40 mg; oral solution 10 mg/5 mL
fda_maxString'''20 mg/day in adults >60 years''' per FDA's 2011-2012 QT-prolongation warning; 40 mg/day in adults ≤60
pill_idText
routesList of String, delimiter: ,Oral
onsetStringAntidepressant effect over 1-2 weeks; full clinical effect 4-6 weeks
durationString24 hours (once-daily dosing)
halflifeString~35 hours'"`UNIQ--ref-00000026-QINU`"'
bioavailabilityString~80% (oral)'"`UNIQ--ref-00000027-QINU`"'
pregnancyStringObservational signal for persistent pulmonary hypertension of the newborn (small absolute risk) and neonatal adaptation syndrome with third-trimester exposure.<sup class="pcp-cn" title="This claim needs a citation.">&#91;[[Pharmacopedia:Citation needed|citation&nbsp;needed]]&#93;</sup>
legalString[[USLegal:Prescription only|Rx-only]] in US. Carries the antidepressant '''Boxed Warning''' for suicidality in children, adolescents, and young adults'"`UNIQ--ref-00000028-QINU`"'